Núbia Boechat - Concepedia

Author

Núbia Boechat

Also Known As

Boechat, N., Boechat, Nubia, Boechat, Núbia, N Boechat, N. A. BOECHAT, N. BOECHAT, N. Boechat, NUBIA BOECHAT, Nubia A. Boechat, Nubia Boechat

228

Publications

4.1K

Citations

H-Index

Concepts

All Affiliations

Fundação Oswaldo Cruz Universidade Federal do Rio de Janeiro Universidade Federal Fluminense Instituto de Tecnologia e Pesquisa Universidade de São Paulo

About

Núbia Boechat is an author at Fundação Oswaldo Cruz specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	33	1.6K
2	Natural Sciences	12	14	578
3	Engineering	10	10	226
4	Health Sciences	2	2	22
5	Anesthesia	1	1	20

Núbia Boechat

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Novel 1,2,3-Triazole Derivatives for Use against <i>Mycobacterium tuberculosis</i> H37Rv (ATCC 27294) Strain Núbia Boechat, Vı́tor F. Ferreira, Sabrina Baptista Ferreira, Journal of Medicinal Chemistry Pharmaceutical SciencePharmacotherapyAntimicrobial ChemotherapyClick ChemistryPharmaceutical Chemistry	2011	282
The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication Carolina Q. Sacramento, Gabrielle R. de Melo, Caroline S. de Freitas, Scientific Reports	2017	236
Synthesis, tuberculosis inhibitory activity, and SAR study of N-substituted-phenyl-1,2,3-triazole derivatives Marilia S. Costa, Núbia Boechat, Érica A. Rangel, Bioorganic & Medicinal Chemistry Derivative (Chemistry)DerivativesMedicineOrganic ChemistryChemistry	2006	216
Design, synthesis, and antiviral activity of new 1H-1,2,3-triazole nucleoside ribavirin analogs M.De L. Ferreira, Luiz C. S. Pinheiro, Osvaldo A. Santos‐Filho, Medicinal Chemistry Research Antiviral ActivityMedicineAntiviral Drug DevelopmentAntiviral TherapyVirology	2013	140
Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo Caroline S. de Freitas, Luiza M. Higa, Carolina Q. Sacramento, PLoS neglected tropical diseases	2019	119
<i>In vitro</i> antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19 Carolina Q. Sacramento, Natalia Fintelman‐Rodrigues, Jairo R. Temerozo, Journal of Antimicrobial Chemotherapy	2021	98
Beyond Members of the <i>Flaviviridae</i> Family, Sofosbuvir Also Inhibits Chikungunya Virus Replication André C. Ferreira, Patrícia A. Reis, Caroline S. de Freitas, Antimicrobial Agents and Chemotherapy	2018	93
Synthesis and evaluation of new difluoromethyl azoles as antileishmanial agents Sabrina Baptista Ferreira, Marilia S. Costa, Núbia Boechat, European Journal of Medicinal Chemistry Medicinal ChemistryBioorganic ChemistryAntileishmanial AgentsNatural SciencesMedicine	2007	87
New Compounds Hybrids 1<i>H</i>‐1,2,3‐Triazole‐Quinoline Against <i>Plasmodium falciparum</i> Núbia Boechat, M.De L. Ferreira, Luiz C. S. Pinheiro, Chemical Biology & Drug Design	2014	86
Evaluation of 7-arylaminopyrazolo[1,5-a]pyrimidines as anti-Plasmodium falciparum, antimalarial, and Pf-dihydroorotate dehydrogenase inhibitors Luís Felipe S.P. Azeredo, Julia Penna Coutinho, Valquíria Aparecida Polisel Jabor, European Journal of Medicinal Chemistry Pf-dihydroorotate Dehydrogenase InhibitorsBiochemistryAntiparasitic AgentMedicineMalaria	2016	79

Page 1